Mesalamine Capsule, Extended Release
Product Images NDC 68682-113

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 68682-113). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oceanside Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Image 01

Image 01
Chemical structure of mesalamine showing a benzene ring with amino, hydroxyl, and carboxyl functional groups.*
FDA Label Image

Image 02

Image 02
Label for Mesalamine Extended-Release Capsules 0.375 g by Oceanside Pharmaceuticals. The label includes the NDC 68682-113-20, indicates the pack contains 120 capsules, and states the product is Rx only. Storage instructions and distribution details by Oceanside Pharmaceuticals, a division of Bausch Health US, LLC, are also present, along with a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.